Our recent results on the function of alternative translational forms and phosphorylation of c-Myc have led us to change our ideas on how c-Myc functions at the molecular level to control growth and apoptosis. We have identified a naturally occurring, downstream- initiated form of c-Myc, termed dMyc, which lacks the N-terminal 100 amino acids. Since it has a severely-truncated transactivation domain, it cannot transactivate through the c-Myc """"""""E"""""""" box DNA binding site. Surprisingly, however, dMyc retains the ability of the full-length c-Myc protein to stimulate proliferation and anchorage-independent growth and induce apoptosis in low serum. We also have data to suggest that several N-terminal c-Myc phosphorylation events, including novel tyrosine phosphorylation by c-Src, appear to be inhibitory to c-Myc function. Therefore, our hypothesis is that transactivation through the EMS Myc/Max element is not necessary for at least some of the biological functions of c-Myc and that the N-terminal 100 amino acids of c-Myc represent an inhibitory domain which modulates the function of c-Myc. In addition, interactions through the N-terminal region with specific regulatory proteins are important for the function and inhibition of function of c-Myc and that these interactions are modulated through specific and regulated phosphorylation events. The following specific aims are designed to test this hypothesis: Specific l focuses on determining the biological and mechanistic role of novel N-terminal phosphorylations for c-Myc function, including N-terminal tyrosine phosphorylation by c-Src and highly- regulated N-terminal serine/threonine phosphorylations.
Specific Aim 2 will be to determine the biological role and molecular properties of dMyc in comparison to the full-length c-Myc protein. Finally, Specific Aim 3 will focus on determining the role of B-Myc and B-Myc phosphorylation in regulating the biological and molecular functions of c-Myc. B-Myc affords an excellent model to examine the N-terminal region since it is a small protein homologous to the N-terminal domain of c-Myc. Our preliminary results and the results of experiments proposed in these specific aims will have major implications for the function of c-Myc.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA047399-10
Application #
2410847
Study Section
Pathology B Study Section (PTHB)
Project Start
1988-04-01
Project End
2001-06-30
Budget Start
1997-09-01
Budget End
1998-06-30
Support Year
10
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Vaknin, Uri A; Hann, Stephen R (2006) The alpha1 subunit of GABAA receptor is repressed by c-myc and is pro-apoptotic. J Cell Biochem 97:1094-103
Hsia, Nelson; Brousal, Jeffrey P; Hann, Stephen R et al. (2005) Recapitulation of germ cell- and pituitary-specific expression with 1.6 kb of the cystatin-related epididymal spermatogenic (Cres) gene promoter in transgenic mice. J Androl 26:249-57
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2005) The ARF tumor suppressor: keeping Myc on a leash. Cell Cycle 4:249-52
Gregory, Mark A; Qi, Ying; Hann, Stephen R (2003) Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278:51606-12
Cornwall, G A; Collis, R; Xiao, Q et al. (2001) B-Myc, a proximal caput epididymal protein, is dependent on androgens and testicular factors for expression. Biol Reprod 64:1600-7
Gregory, M A; Hann, S R (2000) c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt's lymphoma cells. Mol Cell Biol 20:2423-35
Claassen, G F; Hann, S R (2000) A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Proc Natl Acad Sci U S A 97:9498-503
Gregory, M A; Xiao, Q; Cornwall, G A et al. (2000) B-Myc is preferentially expressed in hormonally-controlled tissues and inhibits cellular proliferation. Oncogene 19:4886-95
Lutterbach, B; Hann, S R (1999) c-Myc transactivation domain-associated kinases: questionable role for map kinases in c-Myc phosphorylation. J Cell Biochem 72:483-91
Spotts, G D; Patel, S V; Xiao, Q et al. (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17:1459-68

Showing the most recent 10 out of 23 publications